The Official Website of the Long-Term Investor
Results 11 - 20 of 1609 : Previous 1 2 3 4 5 6 7 8 9 Next
Bristol-Myers Squibb Meets on the Top Line, Misses Where it Counts
Just the facts, Fool.
Is Bristol-Myers Squibb a Buffett Stock?
Let's find out.
19 Clinical Trials Aren't Enough
The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin.
This High-Yield Portfolio Will Beat the Market
48 weeks in and my dividend picks are already beating the market.
Buying on Bad News: Can These Dividend Stocks Weather More Volatility?
Are any of these names in your portfolio -- or on your watchlist?
2 High-Flying Biotechs Face a New Hurdle
Comparing clinical trials can be difficult.
Pharma Focus Is Good For Your Portfolio
Build your own portfolio.
CEO Gaffe of the Week: Bristol-Myers Squibb
Some days, CEOs would be better off staying in bed.
Finding out which companies will reward investors the most.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK